The majority of tumors thrive in their host environment by neutralizing anti-tumor immunoregulatory signals, such as PD1/PDL1 and CTLA4, that block the cytotoxicity of immune cells and result in immunotherapy failure. Here, PDCD1 is linked to neoplasm.